Non-medical prescription use increases the risk for the onset and recurrence of psychopathology: Results from the National Epidemiological Survey on Alcohol and Related Conditions

Addiction

Volumn 106, Issue 12, 2011, Pages 2146-2155

  Schepis, Ty S ^a   Hakes, Jahn K ^b  

^a TEXAS STATE UNIVERSITY   (United States)

^b US Bureau of the Census   (United States)

Author keywords

Analgesics; Benzodiazepines; CNS stimulants; Non medical prescription use; Opioid; Psychopathology; Sedatives

Indexed keywords

CENTRAL DEPRESSANT AGENT; CENTRAL STIMULANT AGENT; PRESCRIPTION DRUG;

ADDICTION; ADULT; ARTICLE; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MENTAL DISEASE; MIDDLE AGED; RECURRENT DISEASE; SELF MEDICATION; STATISTICS;

ADULT; CAUSALITY; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PRESCRIPTION DRUGS; PSYCHOPATHOLOGY; RECURRENCE; SELF MEDICATION; SUBSTANCE-RELATED DISORDERS;

EID: 80455174670     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03520.x     Document Type: Article

References (37)

1. Compton W. M., Volkow N. D. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006; 81: 103-7.
2. Compton W. M., Volkow N. D. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend 2006; 83: S4-7.
3. Manchikanti L. Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources. Pain Physician 2006; 9: 287-321.
4. National Center on Addiction and Substance Use. Controlled prescription drug abuse at epidemic level. J Pain Palliat Care Pharmacother 2006; 20: 61-4.
5. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. NSDUH Series H-38A, HHS Publication no. SMA 10-4856. Rockville, MD: Office of Applied Studies; 2010.
6. Manchikanti L., Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008; 11: S63-88.
7. Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2007: Area Profiles of Drug-Related Mortality. HHS Publication no. SMA 09-4407, DAWN Series D-31. Rockville, MD: Office of Applied Studies; 2010.
8. Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS) Highlights-2007 National Admissions to Substance Abuse Treatment Services. OAS Series #S-45, HHS Publication no. (SMA) 09-4360. Rockville, MD: Office of Applied Studies; 2009.
9. Huang B., Dawson D. A., Stinson F. S., Hasin D. S., Ruan W. J., Saha T. D. etal. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatry 2006; 67: 1062-73.
10. Simoni-Wastila L., Strickler G. Risk factors associated with problem use of prescription drugs. Am J Public Health 2004; 94: 266-8.
11. Schepis T. S., Krishnan-Sarin S. Characterizing adolescent prescription misusers: a population-based study. J Am Acad Child Adolesc Psychiatry 2008; 47: 745-54.
12. Boyd C. J., Young A., Grey M., McCabe S. E. Adolescents' nonmedical use of prescription medications and other problem behaviors. J Adolesc Health 2009; 45: 543-50.
13. McCabe S. E., Boyd C. J., Cranford J. A., Teter C. J. Motives for nonmedical use of prescription opioids among high school seniors in the United States: self-treatment and beyond. Arch Pediatr Adolesc Med 2009; 163: 739-44.
14. Back S. E., Payne R. A., Waldrop A. E., Smith A., Reeves S., Brady K. T. Prescription opioid aberrant behaviors: a pilot study of sex differences. Clin J Pain 2009; 25: 477-84.
15. Subramaniam G. A., Stitzer M. A. Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder. Drug Alcohol Depend 2009; 101: 13-9.
16. Boyd C. J., Teter C. J., West B. T., Morales M., McCabe S. E. Non-medical use of prescription analgesics: a three-year national longitudinal study. J Addict Dis 2009; 28: 232-42.
17. Becker W. C., Fiellin D. A., Desai R. A. Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlates. Drug Alcohol Depend 2007; 90: 280-7.
18. Becker W. C., Sullivan L. E., Tetrault J. M., Desai R. A., Fiellin D. A. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend 2008; 94: 38-47.
19. Goodwin R. D., Hasin D. S. Sedative use and misuse in the United States. Addiction 2002; 97: 555-62.
20. Sansone R. A., Wiederman M. W. The abuse of prescription medications: borderline personality patients in psychiatric versus non-psychiatric settings. Int J Psychiatry Med 2009; 39: 147-54.
21. McCauley J. L., Amstadter A. B., Danielson C. K., Ruggiero K. J., Kilpatrick D. G., Resnick H. S. Mental health and rape history in relation to non-medical use of prescription drugs in a national sample of women. Addict Behav 2009; 34: 641-8.
22. Martins S. S., Keyes K. M., Storr C. L., Zhu H., Chilcoat H. D. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on alcohol and related conditions. Drug Alcohol Depend 2009; 103: 16-24.
23. Markou A., Kosten T. R., Koob G. F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998; 18: 135-74.
24. Brady K. T., Sinha R. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry 2005; 162: 1483-93.
25. McGue M., Iacono W. G., Legrand L. N., Elkins I. Origins and consequences of age at first drink. II. Familial risk and heritability. Alcohol Clin Exp Res 2001; 25: 1166-73.
26. McGue M., Iacono W. G., Legrand L. N., Malone S., Elkins I. Origins and consequences of age at first drink. I. Associations with substance-use disorders, disinhibitory behavior and psychopathology, and P3 amplitude. Alcohol Clin Exp Res 2001; 25: 1156-65.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th edn. Washington, DC: American Psychiatric Association; 2000.
28. Grant B. F., Kaplan K. D. Source and Accuracy Statement for the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 2005.
29. Grant B. F., Kaplan K., Shepard J., Moore T. Source and Accuracy Statement for Wave 1 of the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003.
30. Boyd C. J., McCabe S. E. Coming to terms with the nonmedical use of prescription medications. Subst Abuse Treat Prev Policy 2008; 3: 22.
31. Grant B. F., Dawson D. A., Stinson F. S., Chou P. S., Kay W., Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend 2003; 71: 7-16.
32. Grant B. F., Harford T. C., Dawson D. A., Chou P. S., Pickering R. P. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend 1995; 39: 37-44.
33. Andrade L., Caraveo-Anduaga J. J., Berglund P., Bijl R. V., De Graaf R., Vollebergh W. etal. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) surveys. Int J Methods Psychiatr Res 2003; 12: 3-21.
34. Bonnewyn A., Bruffaerts R., Vilagut G., Almansa J., Demyttenaere K. Lifetime risk and age-of-onset of mental disorders in the Belgian general population. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 522-9.
35. Kessler R. C., Berglund P., Demler O., Jin R., Merikangas K. R., Walters E. E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602.
36. Klein D. N., Shankman S. A., Rose S. Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. Am J Psychiatry 2006; 163: 872-80.
37. Lewinsohn P. M., Hops H., Roberts R. E., Seeley J. R., Andrews J. A. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol 1993; 102: 133-44.